Close
Real Chemistry has introduced IRIS, a predictive analytics platform utilizing AI to offer insights on GLP-1 drugs and the obesity market. IRIS, powered by Real Chemistry's AI and analytics tools, provides users with a live dashboard through an annual subscription that is updated weekly. Additionally, users can access companion market reports published every other month. The inaugural report from IRIS explores the influence of GLP-1 influencers and the evolving landscape for healthcare companies and their marketing teams.
The report highlights a shift in consumer behavior related to GLP-1 drugs, with patients now identifying as influencers and sharing their experiences online. Rita Glaze-Rowe, from Real Chemistry, emphasizes the significance of IRIS in helping medical marketing teams understand the changing sector dynamics. The platform aids in predicting trends in the obesity market, especially with over 100 active GLP-1 clinical trials. IRIS aims to provide actionable insights for marketers, enabling proactive decision-making in a rapidly evolving industry.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
